Webcast overview
As the global economy reopens, government agencies, employers, universities, sports teams, individuals, and families are asking: What can we do to ensure everyone’s safety? COVID-19 testing is a significant part of the answer – and will remain crucial even after vaccines or therapies eventually become available.
KPMG is working with government agencies and leading laboratories to set up COVID-19 testing capabilities and best practices.
Featured speakers
Kristin C. Pothier
Global and National Strategy and Deal Advisory Leader, Healthcare and Life Sciences, KPMG LLP
Natalie Cummins
Senior Vice President, Marketing & Payer Relations, BioReference Laboratories
Kevin Feeley
Chief Financial Officer, BioReference Laboratories
